A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia

Clinical trial NCT00168441 · COMPLETED

Trial details

NCT number: NCT00168441
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Postherpetic Neuralgia

Start date: 2004-06-01
Primary completion: 2005-06-01
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.